5 Results

People

  1. Herr
    Herr
  2. Begg
    Begg
  3. Cordon-Cardo
    Cordon-Cardo
  4. Zhang
    Zhang
  5. Bach
    Bach
  6. Bajorin
    Bajorin
  7. Bochner
    Bochner
  8. Boyle
    Boyle
  9. Dalbagni
    Dalbagni
  10. Fair
    Fair

Groups

  1. Surgery (5)
  2. Urology (5)
  3. Biostatistics Service (3)
  4. Epidemiology and Biostatistics (3)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  6. Department of Medicine (2)
  7. Epidemiology Service (2)
  8. Genitourinary Oncology Service (2)
  9. Health Outcomes Research Group (2)
  10. Molecular Pharmacology and Chemistry Program Faculty (2)
  1. "Oxford University Press"
  2. "Surgery"
  3. "Harry Herr"
Formats
  1. Journal Article (4)
  2. Guidelines (1)
Groups
  1. Surgery (5)
  2. Urology (5)
  3. Biostatistics Service (3)
  4. Epidemiology and Biostatistics (3)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  6. Department of Medicine (2)

More Groups

People
  1. Harry Herr (5)
  2. Carlos Cordon-Cardo (2)
  3. Colin Begg (2)
  4. Zuo-Feng Zhang (2)
  5. Alvaro Sarkis (1)
  6. Bernard Bochner (1)

More People

Years
  1. 2019 (1)
  2. 2006 (1)
  3. 2003 (1)
  4. 1995 (1)
  5. 1993 (1)
Publications
  1. Annals of Oncology (2)
  2. JNCI: Journal of the National Cancer Institute (2)
  3. American Journal of Epidemiology (1)
Publishers
  1. Oxford University Press (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - An international collaborative multi-stakeholder effort: Under the auspices of the EAU and ESMO Guidelines Committees†
    Guidelines

    Horwich, A.; Babjuk, M.; Bellmunt, J.; Bruins, H. M.; De Reijke, T. M.; De Santis, M.; Gillessen, S.; James, N.; Maclennan, S.; Palou, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
    Journal Article

    Maluf, F. C.; Cordon-Cardo, C.; Verbel, D. A.; Satagopan, J. M.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Annals of Oncology (2006)

    Fulltext@MSK | Save
  • Adherence to surveillance among patients with superficial bladder cancer
    Journal Article

    Schrag, D.; Hsieh, L.; Rabbani, F.; Bach, P. B.; Herr, H.; Begg, C. B.
    JNCI: Journal of the National Cancer Institute (2003)

    Fulltext@MSK | Save
  • Methodology for evaluating the incidence of second primary cancers with application to smoking-relted cancers from the Surveillance, Epidmiology, and End Results (SEER) program
    Journal Article

    Begg, C. B.; Zhang, Z. F.; Sun, M.; Herr, H. W.; Schantz, S. P.
    American Journal of Epidemiology (1995)

    Fulltext@MSK | Save
  • Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
    Journal Article

    Sarkis, A. S.; Dalbagni, G.; Cordon-Cardo, C.; Zhang, Z. F.; Sheinfeld, J.; Fair, W. R.; Herr, H. W.; Reuter, V. E.
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save